Search Results 421-430 of 18343 for prednisone

1. Clinical trials - Oncology (Medical)

   ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

2. Clinical trials - Oncology (Medical)

   ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

3. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   ... prednisone or equivalent are permitted;; Adrenal replacement steroid doses including doses > 10 mg daily prednisone are permitted;; A brief (less than 3 weeks) ...

4. Clinical trials - Oncology (Medical)

   ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

5. Stevens-Johnson syndrome - Diagnosis & treatment - Mayo Clinic

   Tests and procedures used to diagnose Stevens-Johnson syndrome include: A review of your medical history and a physical exam. Health care providers often ...

6. VG161 in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma - Mayo Clinic

   (> 10 mg daily prednisone equivalent) or other immunosuppressive medications within 14 days prior to dosing. Inhaled or topical steroids, and adrenal ...

7. Desonide (topical application route) - Side effects & dosage - Mayo Clinic

   Desonide topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions (eg, atopic dermatitis). This medicine is a ...

8. Clinical trials - Oncology (Medical)

   ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

9. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 - Mayo Clinic

   at a total daily dose of > 10 mg of prednisone (or equivalent) prior to randomization. 4. Have poorly controlled (> 1/week) generalized or complex partial ...

10. Macroglobulinemia Clinical Trials - Mayo Clinic Research

    ... prednisone (M-CHOP) and, subsequently, in combination with cyclophosphamide, doxorubicin, and prednisone (CHP) plus polatuzumab vedotin (CHP-pola) in ...